New Life Pharma LLC recalls Semaglutide Inj
- Recalling company
- New Life Pharma LLC
- Product
- Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.
- Reason
- Lack of Assurance of Sterility
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Feb 26, 2026
- Reported
- Mar 11, 2026
- Distribution
- OH
- Status
- Ongoing
- Quantity
- 820 vials
- Lot / codes
- Lot 241113, Exp Date 11/30/2026 & Lot 250103, Exp Date 1/31/2027
- Company location
- Northvale, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0392-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0392-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.